BACKGROUND: The known impairments of the cardiovascular system in Parkinson´s disease (PD) are caused by autonomic dysfunction and manifested mainly in postural hypotension, chronotropic insufficiency, and reduced heart rate variability. Other dysfunctions, mainly stress response, arrhythmia occurrence, and heart morphology changes, are still the subject of research. OBJECTIVES: To assess the heart rate and blood pressure reaction during exercise, advanced measurements of heart volumes and mass using cardiac magnetic resonance (CMR), and occurrence of arrhythmias in PD patients. METHODS: Thirty PD patients (19 men, mean age 57.5 years) without known cardiac comorbidities underwent bicycle ergometry, electrocardiogram Holter monitoring and CMR. Exercise and CMR parameters were compared with controls (24 subjects for ergometry, 20 for CMR). RESULTS: PD patients had lower baseline systolic blood pressure (SBP) (117.8 vs. 128.3 mmHg, p < 0.01), peak SBP (155.8 vs. 170.8 mmHg, p < 0.05), and lower heart rate increase (49.7 vs. 64.3 beats per minute, p < 0.01). PD patients had higher indexed left and right ventricular end-diastolic volumes (68.5 vs. 57.3, p = 0.003 and 73.5 vs. 61.0 mL/m2 , respectively) and also indexed left and right ventricular end-systolic volumes (44.1 vs. 39.0, p = 0.013 and 29.0 vs. 22.0 mL/m2 , p = 0.013, respectively). A high prevalence of atrial fibrillation (8 subjects, 26.7%) was found. CONCLUSIONS: This novel study combining functional and structural approaches showed that PD is linked with weaker blood pressure and heart rate reaction during exercise, increased myocardial mass and heart volumes compared to controls, and a high prevalence of atrial fibrillation.

Central European Institute of Technology Brno Czech Republic

Department of Internal Medicine Cardiology St Anne 's University Hospital Faculty of Medicine Masaryk University Brno Czech Republic

Department of Neurology St Anne 's University Hospital Masaryk University Brno Czech Republic

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

International Clinical Research Center St Anne 's University Hospital Faculty of Medicine Masaryk University Brno Czech Republic

Zobrazit více v PubMed

De Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525‐538. PubMed

Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med. 2003;348:1356‐1364. PubMed

Lee A, Gilbert RM. Epidemiology of Parkinson disease. Neurol Clin. 2016;34:955‐965. PubMed

Todorova A, Jenner P, Chaudhuri KR. Non‐motor Parkinson' s: intergral to motor Parkinson' s, yet often neglected. Pract Neurol. 2014;14(5):310‐322. doi:10.1136/practneurol-2013-000741 Epub 2014 Apr 3. PubMed DOI PMC

Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson's disease and other synucleinopathies. Mov Disord. 2018;33(3):372‐390. doi:10.1002/mds.27344 PubMed DOI PMC

Mochizuki H, Ebihara Y, Ugawa Y, et al. Prolongation and cardiac 123I‐MIBG uptake reduction in Parkinson's disease. Eur Neurol. 2015;74:107‐111. PubMed

Strano S, Fanciulli A, Rizzo M, et al. Cardiovascular dysfunction in untreated Parkinson's disease: a multimodality assessment. J Neurol Sci. 2016;370:251‐255. PubMed

Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson's disease and healthy normals. Med Sci Sports Exerc. 1999;31:761‐766. PubMed

Protas EJ, Stanley RK, Jankovic J, MacNeill B. Cardiovascular and metabolic responses to upper‐ and lower‐extremity exercise in men with idiopathic Parkinson's disease. Phys Ther. 1996;76:34‐40. PubMed

Pérez T, Tijero B, Gabilondo I, et al. Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension. J Hum Hypertens. 2015;9(10):604‐609. PubMed

Miyasato RS, Silva‐Batista C, Peçanha T, et al. Cardiovascular responses during resistance exercise in patients with Parkinson disease. PM&R. 2018;10(11):1145‐1152. PubMed

Kamieniarz A, Michalska J, Marszałek W, et al. Detection of postural control in early Parkinson's disease: clinical testing vs. modulation of center of pressure. PloS One. 2021;16(1):e0245353. doi:10.1371/journal.pone.0245353 PubMed DOI PMC

DiFrancisco‐Donoghue J, Elokda A, Lamberg EM, Bono N, Werner WG. Norepinephrine and cardiovascular responses to maximal exercise in Parkinon's disease on and off medication. Mov Disord. 2009;24(12):1773‐1778. PubMed

Barbic F, Perego F, Canesi M, et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson's disease without orthostatic hypotension. Hypertension. 2007;49:120‐126. PubMed

Mochizuki H, Ebihara Y, Ugawa Y, et al. PR prolongation and cardiac 123I‐MIBG uptake reduction in Parkinson's disease. Eur Neurol. 2015;74:107‐111. PubMed

Ishizaki F, Harada T, Yoshinaga H, Nakayama T, Yamamura Y. Nakamura S. Prolonged QTc intervals in Parkinson's disease–relation to sudden death and autonomic dysfunction. No to Shinkei. 1996;48:443‐448. PubMed

Han S, Moon I, Choi EK, et al. Oh S. Increased atrial fibrillation risk in Parkinson's disease: a nationwide population‐based study. Ann Clini Translati Neurol. 2021;8(1):238‐246. PubMed PMC

Panovský R, Pešl M, Holeček T, et al. Cardiac profile of the Czech population of Duchenne muscular dystrophy patients: a cardiovascular magnetic resonance study with T1 mapping. Orphanet J Rare Dis. 2019;14(1):10. PubMed PMC

Schulz‐Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson. 2013;15(1):35. PubMed PMC

Mojica‐Pisciotti ML, Panovský R, Masárová L, et al. Left atrium phasic impairments in paroxysmal atrial fibrillation patients assessed by cardiovascular magnetic resonance feature tracking. Sci Rep Prosinec. 2022;12(1):7539. PubMed PMC

Lauhoff P, Murphy N, Doherty C. Horgan NF.A controlled clinical trial investigating the effects of cycle ergometry training on exercise tolerance, balance and quality of life in patients with Parkinson's disease. Disabil Rehabil. 2013;35(5):382‐387. doi:10.3109/09638288.2012.694962 Epub 2012 Jul 2. PubMed DOI

Hürlimann A, Pastore‐Wapp M, van Beek J, Hirsch MA, van Wegen EEH, Vanbellingen T. Graded peak cycle ergometer test for cognitively impaired patients with Parkinson's disease: a pilot study. Physiother Theory Pract. 2023;39(6):1249‐1256. doi:10.1080/09593985.2022.2034078 PubMed DOI

Reuter I, Engelhardt M, Freiwaldt J, Baas H. Exercise test in Parkinson's disease. Clin Auton Res. 1999;9(3):129‐134. doi:10.1007/BF02281625 PubMed DOI

Nakamura T, Hirayama M, Yamashita F, et al. Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson's disease. Mov Disord. 2010;25(9):1183‐1189. doi:10.1002/mds.23127 PubMed DOI

Speelman AD, Groothuis JT, van Nimwegen M, et al. Cardiovascular responses during a submaximal exercise test in patients with Parkinson's disease. J Parkinsons Dis. 2012;2(3):241‐247. doi:10.3233/JPD-2012-012111 PubMed DOI

Hong CT, Chan L, Wu D, Chen WT, Chien LN. Association between Parkinson's disease and atrial fibrillation: a population‐based study. Front Neurol. 2019;10:22. doi:10.3389/fneur.2019.00022 eCollection 2019. PubMed DOI PMC

Dai H, Zhang Q, Much AA, et al. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990‐2017: results from the Global Burden of Disease Study 2017. Eur Heart J Qual Care Clin Outcomes. 2021;7:574‐582. doi:10.1093/ehjqcco/qcaa061 PubMed DOI PMC

Piqueras‐Flores J, Lopéz‐Garcia A, Moreno‐Reig A, et al. Structural and functional alterations of the heart in Parkinson's disease. Neurol Res. 2018;40(1):53‐61. doi:10.1080/01616412.2017.1390933 Epub 2017 Oct 23. PubMed DOI